BioCrossroads Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
3
- Investments
-
77
- Portfolio
-
17
- Exits
-
36
BioCrossroads General Information
Company Description
Founded in 2002, BioCrossroads is a venture capital firm based in Indianapolis, Indiana. The firm prefers to invest in the biotechnology, pharmaceutical, medical device, diagnostic, ag-tech, biotech, and health information technology sectors.
Business Details
Website
www.biocrossroads.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- 1210 Waterway Boulevard
- Suite 5000
- Indianapolis, IN 46202
- United States
BioCrossroads Investments (77)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Antigenix Therapeutics | 18-Nov-2025 | Seed Round | Drug Discovery | Pre-Clinical Trials | ||
| Gate Neurosciences | 05-Oct-2022 | Other Pharmaceuticals and Biotechnology | Generating Revenue | |||
| Sabanto | 01-Jul-2022 | Machinery (B2B) | Generating Revenue | |||
| MBX Biosciences | 01-Jan-2022 | Drug Discovery | Generating Revenue | |||
| Novosteo | 29-Dec-2021 | Pharmaceuticals | Pre-Clinical Trials | |||
| Lumavate | 01-Dec-2021 | Software Development Applications | Out of Business | |||
| Scioto Biosciences | 12-Nov-2021 | Drug Delivery | Clinical Trials - Phase 2 | |||
| Kovina Therapeutics | 29-Jun-2021 | Drug Discovery | Pre-Clinical Trials | |||
| Gate Neurosciences | 29-Mar-2021 | Seed Round | Other Pharmaceuticals and Biotechnology | Generating Revenue | ||
| Scioto Biosciences | 10-Aug-2020 | Early Stage VC | Drug Delivery | Clinical Trials - Phase 2 |
BioCrossroads Exits (36)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Zorion Medical | 28-Oct-2026 | Out of Business | |
| SpeechVive | 14-Jun-2026 | ||
| AgeneBio | 01-Feb-2026 | ||
| FAST BioMedical | 17-Jul-2025 | ||
| Gate Neurosciences | 27-May-2025 | ||
| Curvo Labs | 20-May-2025 | ||
| Lodos Theranostics | 20-May-2025 | ||
| Apexian Pharmaceuticals | 01-Mar-2025 | ||
| Lumavate | 21-Nov-2024 | Out of Business | |
| MBX Biosciences | 13-Sep-2024 | IPO |
BioCrossroads Investments by Industry, Year, and Region
BioCrossroads Co-Investors (25)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Luson BioVentures | 2 |
|
|
||
| Frazier Healthcare Partners |
|
|
|||
| New Enterprise Associates |
|
|
|||
| OrbiMed |
|
|
|||
| T. Rowe Price Group |
|
|
BioCrossroads FAQs
-
What is BioCrossroads?
Founded in 2002, BioCrossroads is a venture capital firm based in Indianapolis, Indiana.
-
When was BioCrossroads founded?
BioCrossroads was founded in 2002.
-
Where is BioCrossroads headquartered?
BioCrossroads is headquartered in Indianapolis, IN.
-
What is BioCrossroads's total asset value?
BioCrossroads has around in total assets under management.
-
How many investments has BioCrossroads made?
BioCrossroads has made 77 investments.
-
What has BioCrossroads invested in?
BioCrossroads has made numerous investments in companies like Antigenix Therapeutics, Gate Neurosciences, and Sabanto within the Drug Discovery, Pharmaceuticals and Biotechnology, and Machinery (B2B) industries.
-
What has BioCrossroads invested in recently?
BioCrossroads's latest investment was on 18-Nov-2025 in Antigenix Therapeutics, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process